SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-20-127958
Filing Date
2020-11-20
Accepted
2020-11-20 16:15:42
Documents
4
Group Members
2019B CAYMAN LTDCCP IV GP LTD.CITIC CAPITAL CHINA PARTNERS IV, L.P.CITIC CAPITAL PARTNERS LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2036536d1_sc13da.htm SC 13D/A 134084
2 EXHIBIT 14 tm2036536d1_ex14.htm EX-14 82496
3 EXHIBIT 15 tm2036536d1_ex15.htm EX-15 83683
4 EXHIBIT 16 tm2036536d1_ex16.htm EX-16 58666
  Complete submission text file 0001104659-20-127958.txt   360906
Mailing Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125
Business Address 18TH FL, JIALONG INTERNATIONALBUILDING 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT BEIJING F4 100125 86-10-6598-3111
China Biologic Products Holdings, Inc. (Subject) CIK: 0001369868 (see all company filings)

IRS No.: 752308816 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-83122 | Film No.: 201332707
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 28/F, CITIC TOWER, 1 TIM MEI AVENUE, CENTRAL K3 00000
Business Address 28/F, CITIC TOWER, 1 TIM MEI AVENUE, CENTRAL K3 00000 852-3710-6888
CITIC Capital Holdings Ltd (Filed by) CIK: 0001677151 (see all company filings)

IRS No.: 000000000 | State of Incorp.: K3 | Fiscal Year End: 1231
Type: SC 13D/A